| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |